P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays

Podobne zapisy

• P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific
  od: Wieczorek, L, i wsp.
  Wydane: (2009)
• P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
  od: Matyas, GR, i wsp.
  Wydane: (2009)
• The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization.
  od: Bruce K Brown, i wsp.
  Wydane: (2012-01-01)
• The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization
  od: Brown, Bruce K., i wsp.
  Wydane: (2012)
• P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
  od: Chenine, A, i wsp.
  Wydane: (2009)